The soluble form of CD5 (sCD5) can be found at low concentrations (pg/mL range) in the serum of healthy individuals, generated through proteolytic cleavage upon lymphocyte activation [28]; sCD5 has been recently demonstrated to exert an immunomodulatory effects on experimental tumor models [29]. The gene discussed is CD5; the disease is neoplasm.